These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 33193122)

  • 21. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
    Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
    Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency Determination of Carbapenem-Resistant Klebsiella Pneumoniae (CRKP) Isolated from hospitals in Isfahan of Iran and Evaluation of Synergistic Effect of Colistin and Meropenem on them.
    Gheitani L; Fazeli H; Moghim S; Nasr Isfahani B
    Cell Mol Biol (Noisy-le-grand); 2018 Jan; 64(1):70-74. PubMed ID: 29412797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo Antimicrobial Activities of Ceftazidime/Avibactam Alone or in Combination with Aztreonam Against Carbapenem-Resistant Enterobacterales.
    Lu G; Tang H; Xia Z; Yang W; Xu H; Liu Z; Ni S; Wang Z; Shen J
    Infect Drug Resist; 2022; 15():7107-7116. PubMed ID: 36506837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates.
    Peck KR; Kim MJ; Choi JY; Kim HS; Kang CI; Cho YK; Park DW; Lee HJ; Lee MS; Ko KS
    J Med Microbiol; 2012 Mar; 61(Pt 3):353-360. PubMed ID: 22016557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections.
    Bhowmick T; Weinstein MP
    Infect Dis Ther; 2020 Dec; 9(4):757-767. PubMed ID: 33017041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of a double-carbapenem combinations against carbapenem-resistant Gram-negative bacteria.
    Lu J; Qing Y; Dong N; Liu C; Zeng Y; Sun Q; Shentu Q; Huang L; Wu Y; Zhou H; Shen Z; Zhang R
    Saudi Pharm J; 2022 Jun; 30(6):849-855. PubMed ID: 35812137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of antibacterial activities of colistin, rifampicin and meropenem combinations against NDM-1-producing Klebsiella pneumoniae in 24 h in vitro time-kill experiments.
    Lagerbäck P; Khine WW; Giske CG; Tängdén T
    J Antimicrob Chemother; 2016 Aug; 71(8):2321-5. PubMed ID: 27334665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Will ceftazidime/avibactam plus aztreonam be effective for NDM and OXA-48-Like producing organisms: Lessons learnt from
    Pragasam AK; Veeraraghavan B; Shankar BA; Bakthavatchalam YD; Mathuram A; George B; Chacko B; Korula P; Anandan S
    Indian J Med Microbiol; 2019; 37(1):34-41. PubMed ID: 31424008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of carbapenemase genes among carbapenem-nonsusceptible
    Castanheira M; Deshpande LM; Mendes RE; Doyle TB; Sader HS
    JAC Antimicrob Resist; 2022 Oct; 4(5):dlac098. PubMed ID: 36196444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Colistin, Fosfomycin and Meropenem/Vaborbactam on Carbapenem-Resistant
    Shrief R; El-Ashry AH; Mahmoud R; El-Mahdy R
    Infect Drug Resist; 2022; 15():6203-6214. PubMed ID: 36324668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of combination therapy in BALB/c mice injected with carbapenem-resistant Enterobacteriaceae strains.
    Salloum NA; Kissoyan KA; Fadlallah S; Cheaito K; Araj GF; Wakim R; Kanj S; Kanafani Z; Dbaibo G; Matar GM
    Front Microbiol; 2015; 6():999. PubMed ID: 26441926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the Efficacies of Carbapenem/β-Lactamase Inhibitors Against Carbapenem-Resistant Gram-Negative Bacteria
    El Hafi B; Rasheed SS; Abou Fayad AG; Araj GF; Matar GM
    Front Microbiol; 2019; 10():933. PubMed ID: 31114565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in the Distribution of Species, Carbapenemases, Sequence Types, Antimicrobial Heteroresistance and Mortality Rates Between Pediatric and Adult Carbapenemase-Producing
    Yu H; Ma D; Liu B; Yang S; Lin Q; Yu R; Jia X; Niu S; Zhang Q; Huang S
    Front Med (Lausanne); 2022; 9():827474. PubMed ID: 35360726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbiological Characteristics of Carbapenem-Resistant
    Xie S; Fu S; Li M; Guo Z; Zhu X; Ren J; Hu F
    Infect Drug Resist; 2020; 13():1163-1169. PubMed ID: 32368107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of the
    Kilic U; Koroglu M; Olmez M; Altindis M
    Microb Drug Resist; 2020 May; ():. PubMed ID: 32401692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance.
    Ku YH; Chen CC; Lee MF; Chuang YC; Tang HJ; Yu WL
    J Microbiol Immunol Infect; 2017 Dec; 50(6):931-939. PubMed ID: 28716360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbapenemase detection by NG-Test CARBA 5-a rapid immunochromatographic assay in carbapenem-resistant
    Zhu Y; Jia P; Li X; Wang T; Zhang J; Zhang G; Duan S; Kang W; Xu Y; Yang Q
    Ann Transl Med; 2021 May; 9(9):769. PubMed ID: 34268382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
    Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
    Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand.
    Rimrang B; Chanawong A; Lulitanond A; Wilailuckana C; Charoensri N; Sribenjalux P; Phumsrikaew W; Wonglakorn L; Kerdsin A; Chetchotisakd P
    J Antimicrob Chemother; 2012 Nov; 67(11):2626-30. PubMed ID: 22796889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-Border Emergence of Escherichia coli Producing the Carbapenemase NDM-5 in Switzerland and Germany.
    Chakraborty T; Sadek M; Yao Y; Imirzalioglu C; Stephan R; Poirel L; Nordmann P
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33361340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.